Figure 3From: Evaluation of reactive oxygen metabolites in patients with non-small cell lung cancer after chemotherapyROMs levels (U. CARR) before and after 2ndcourse of chemotherapy in patients with non-small cell lung cancer classified as responders (complete response/partial response) and non-responders (stable disease/progressive disease). Individual paired data and mean ± SD are shown. a) A significant decrease in ROMs level is observed in responders (p = 0.014, paired t-test). b) No significant difference in ROMs levels is found in nonresponders (p = 0.387, paired t-test).Back to article page